Enveric Biosciences, Inc. (ENVB)
NASDAQ: ENVB · Real-Time Price · USD
5.67
+0.70 (14.08%)
Nov 18, 2025, 4:00 PM EST - Market closed
Enveric Biosciences Market Cap
Enveric Biosciences has a market cap or net worth of $2.94 million as of November 19, 2025. Its market cap has decreased by -33.00% in one year.
Market Cap
2.94M
Enterprise Value
-818.85K
1-Year Change
-33.00%
Ranking
Category
Stock Price
$5.67
Market Cap Chart
Since December 31, 2020, Enveric Biosciences's market cap has decreased from $135.21B to $2.94M, a decrease of -100.00%. That is a compound annual growth rate of -88.90%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 18, 2025 | 2.99M | -18.09% |
| Dec 31, 2024 | 3.64M | 20.78% |
| Dec 29, 2023 | 3.02M | -30.19% |
| Dec 30, 2022 | 4.32M | -85.19% |
| Dec 31, 2021 | 29.19M | -99.98% |
| Dec 31, 2020 | 135.21B | - |
| Dec 31, 2020 | 135.21B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 914.81B |
| Johnson & Johnson | 480.85B |
| AbbVie | 413.57B |
| UnitedHealth Group | 290.34B |
| AstraZeneca | 277.65B |
| Novartis AG | 255.14B |
| Merck & Co. | 230.48B |
| Abbott Laboratories | 226.11B |